Ultrafast Metaphotonic PCR Chip with Near-Perfect Absorber.

Polymerase chain reaction (PCR) is the gold standard for nucleic acid amplification and quantification in diverse fields such as life sciences, global health, medicine, agricultural science, forensic science, and environmental science for global sustainability. However, implementing a cost-effective PCR remains challenging for rapid preventive medical action to the widespread pandemic diseases due to the absence of highly efficient and low-cost PCR chip-based POC molecular diagnostics. Here, this work reports an ultrafast metaphotonic PCR chip as a solution of a cost-effective and low-power-consumption POC device for the emerging global challenge of sustainable healthcare.

Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.

Introduction: The use of arginine vasopressin (AVP) and terlipressin to treat hypotension in preterm neonates is increasing. Our aim was to review the available evidence on the efficacy and safety of AVP and terlipressin for use in preterm neonates.

Methods: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar from inception to September 2021 were searched for studies of AVP and terlipressin in the treatment of hypotension of any cause in preterm neonates.

Space-Time-Modulated Reconfigurable Metamaterial Based on a Field-Focused Cavity for Nonreciprocal Transmission Control and Frequency Conversion.

Lorentz reciprocity is a fundamental physical property limiting advanced wave propagation control. Previously, special materials and magnetic bias were used to break the reciprocity; however, the approaches are limited by the bulky and costly implementation. To achieve nonreciprocity without magnetic bias, space-time-modulated metamaterials have been investigated for far-field wave propagation control.

Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review.

Background: The use of vasoactive agents like arginine vasopressin (AVP) and terlipressin to treat hypotension or persistent pulmonary hypertension in critically ill preterm neonates is increasing. Therefore, a systematic review of the available data on dosing, efficacy and safety of AVP and terlipressin in this patient population appears beneficial.

Methods: We will conduct a systematic review of the available evidence on the use of AVP and terlipressin for the treatment of hypotension or persistent pulmonary hypertension in preterm neonates.